An observational study in Musculoskeletal Disorders and Among Egyptian Students in the Faculty of Applied Arts, sponsored by Cairo University. Not yet recruiting. Open to participants aged 20 Years to 22 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-03.
Sponsored by Cairo University · Observational
This observational cross-sectional study aims to determine the prevalence of musculoskeletal disorders (MSDs) among Egyptian students in the Faculty of Applied Arts. Using the Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E), the study will assess the prevalence, distribution, and associated factors of musculoskeletal symptoms over the last 12 months and 7 days. A sample of 250 participants, aged 20-22 years and of both genders, will be recruited. Exclusion criteria include obesity, pregnancy, history of neuropathy, unstable medical conditions, or trauma-related musculoskeletal problems. The results will provide insights into MSD prevalence and help guide interventions for this population.
Study Title: Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts
Study Design:
This is an observational, cross-sectional study aimed at investigating the prevalence of musculoskeletal disorders (MSDs) and associated risk factors among Egyptian students enrolled in the Faculty of Applied Arts during their last three academic years. The study will collect demographic data (age, gender) and assess musculoskeletal symptoms using the Nordic Musculoskeletal Questionnaire (NMQ-E).
Study Population:
The target population includes approximately 9,600 students from the Faculty of Applied Arts in Egypt. A sample of 250 participants will be recruited based on eligibility criteria.
Inclusion Criteria:
Egyptian students from the Faculty of Applied Arts. Age range: 20-22 years. Both genders included.
Exclusion Criteria:
Obesity. Pregnancy. History of neuropathy or other neurological disorders such as lumbar plexopathy, spinal stenosis, and nerve root compression.
Unstable medical conditions. History of central nervous system malignancy (primary or metastatic). Musculoskeletal problems due to trauma or previous surgery.
Sample Size Calculation:
The sample size was determined using a sample size calculator with a confidence interval of 95% and α level of 0.05. From a population of 9,600, a minimum of 250 participants was required to achieve statistical power.
Instrumentations:
The Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E) will be utilized. The NMQ is a validated tool for assessing musculoskeletal symptoms, including pain prevalence and anatomical distribution.
Key Sections of NMQ-E:
Section 1: 40 forced-choice items identifying musculoskeletal problem areas, supported by a body map. Symptoms over the last 12 months and the past 7 days will be evaluated.
Section 2: Additional questions on neck, shoulders, and lower back, covering symptom duration, functional impact, professional assessments, and recent musculoskeletal problems.
Procedure:
Participants will be recruited from the Faculty of Applied Arts and asked to complete the NMQ-E online or in person. Data on musculoskeletal symptoms and ergonomic practices will be collected over a specific timeframe.
Validity and Reliability of NMQ-E:
Validity:
Content validity is supported by expert review and alignment with established measures of musculoskeletal health.
Criterion validity demonstrated strong correlations between NMQ responses and clinical assessments (sensitivity: 66-92%; specificity: 71-88%).
Reliability:
High test-retest reliability observed in various populations. Internal consistency confirmed via Cronbach's alpha.
Data Analysis and Statistical Design:
The collected data will be analyzed using statistical software, employing:
Descriptive statistics (mean, standard deviation, percentages). Statistical significance set at p \< 0.05.
668 studies on the registry are indexed under Musculoskeletal Diseases; 161 are open to participants now.
This study's planned enrollment of 250 is above the median of 132 across 208 observational studies indexed under Musculoskeletal Diseases.
Browse Musculoskeletal Diseases studies →Cairo University is the lead sponsor of 4,907 studies on the registry; 1,445 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
students enrolled in the Faculty of Applied Art at a university in Egypt
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace. It is commonly used in occupational health and ergonomic assessments to gather information about the prevalence and severity of musculoskeletal issues such as pain, discomfort, and limitations in movement. The NMQ typically includes questions about specific body regions (e.g. neck, shoulders, back, wrists) and asks individuals to report any symptoms they may be experiencing in those areas. This information can help identify potential risk factors for musculoskeletal disorders and guide interventions to prevent or manage these conditions in the workplace (Namnik et al., 2016). • Section 1: a general questionnaire of 40 forced-choice items identifying areas of the body causing musculoskeletal problems. Completion is aided by a body map to indicate nine symptom sites being neck, shoulders, upper back, elbows, low back, wrist/hands, hips/thi
musculoskeletal symptoms
information on musculoskeletal symptoms experienced by participants,
Time frame: one month
No study locations are listed for this record.
Start is estimated for Jan 2025; primary completion for Apr 2025, 3 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.